# Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer Which Has Spread

> clinical trial · VERIFIED · 2026-07-31

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Stage III Cutaneous Melanoma AJCC v7

- Company: National Cancer Institute (NCI)
- Sector: Stage III Cutaneous Melanoma AJCC v7
- Primary source: https://clinicaltrials.gov/study/NCT02196181

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.